Centogene Total Liab from 2010 to 2024
| CNTG Stock | USD 0.10 0.02 16.67% |
Total Liabilities | First Reported 2017-12-31 | Previous Quarter 102.4 M | Current Value 102.4 M | Quarterly Volatility 24.6 M |
Check Centogene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Centogene's main balance sheet or income statement drivers, such as Tax Provision of 301.4 K, Interest Income of 219.4 K or Discontinued Operations of 4.3 M, as well as many indicators such as Price To Sales Ratio of 0.61, Dividend Yield of 0.0 or Days Sales Outstanding of 79.46. Centogene financial statements analysis is a perfect complement when working with Centogene Valuation or Volatility modules.
Centogene | Total Liab |
Currently Active Assets on Macroaxis
When determining whether Centogene B V is a strong investment it is important to analyze Centogene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Centogene's future performance. For an informed investment choice regarding Centogene Stock, refer to the following important reports:Check out the analysis of Centogene Correlation against competitors. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centogene. If investors know Centogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.39) | Revenue Per Share 1.723 | Quarterly Revenue Growth (0.08) | Return On Assets (0.27) | Return On Equity (13.75) |
The market value of Centogene B V is measured differently than its book value, which is the value of Centogene that is recorded on the company's balance sheet. Investors also form their own opinion of Centogene's value that differs from its market value or its book value, called intrinsic value, which is Centogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centogene's market value can be influenced by many factors that don't directly affect Centogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Centogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Centogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.